Editorial: Beyond contraception - advancing research and innovations in sexual and reproductive health to better meet the needs of women in Low-and middle-income countries.
KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS - The Manila Times
KDventures announces that Organon has discontinued the development of the previous portfolio company Forendos’ drug candidate for PCOS The Manila Times
Detecting the body's reproductive hormonal brake against tissue overgrowth: Micrin/SgII-70.
A new humoral factor has been detected, within a project aiming to disclose the body's reproductive hormonal brake against tissue overgrowth, micrin ('my-crin'). Factor purification involved fractionation of ovine and …